Jim Segermark

Jim Segermark - Panelist

President & CEO, InSitu Biologics

Jim has been the founder, inventor, investor, and owner operator of numerous medical device and biotechnology ventures.  Jim has as an extensive record of developing, managing and selling medical related companies.  Jim has also established successful joint ventures and acted as a project consultant for strategic medtech opportunities.  Jim is the President and Chief Executive Officer of InSitu Biologics, Inc., St. Paul, Minnesota, a company that he founded upon assigning licensing the core hydrogel technology invented by scientists at The Cleveland Clinic Foundation.  InSitu, an early stage company that is testing AnestaGel – a non-opiate post-surgical pain drug – completed a RegD Private Offering in January 2018 and open a RegA+ Initial Public Offering in July of 2018.